Last week saw the annual meeting of running of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). At the commercial exhibition associated with the event Covidien showed three innovative surgical devices which it claims are designed to provide significant benefits to surgeons and improve patient outcomes. The three are the Versaport™ bladeless optical 5 mm trocar and two new line extensions to the LigaSure™ 5 mm blunt tip sealer/divider portfolio.
Versaport bladeless optical 5 mm trocar
Provides clear visualization of the tissue layers during insertion in laparoscopic and thoracic procedures. The proprietary cannula design offers excellent fixation for port security and stability. The low-profile design delivers optimal maneuverability, even when the trocar is used in small spaces.
Ligasure new shaft lengths
The Company also has broadened its line of vessel sealing devices with the introduction of two new shaft lengths – 20 cm and 44 cm – in its LigaSure 5 mm blunt tip sealer/divider portfolio. This expanded portfolio will offer surgeons more versatility when operating on patients with different body shapes and sizes. Surgeons worldwide have relied on the 37 cm LigaSure 5 mm blunt tip sealer/divider for the device’s cutting length, atraumatic grasping, cutting independent of sealing, fast sealing and consistent performance.
“Covidien prides itself on its strong legacy of surgical device innovation. The Company has launched 100 new products over the last five years and, by increasing our investments in research and development, we’re on track to launch another 50 new products over the next two years,” said Paul Hermes, Chief Technology Officer, Covidien Surgical Solutions. “The new products were designed to provide significant enhancements to surgeons so they can perform minimally invasive surgery more effectively.”
The full press release can be found here